Atlas Trials

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

Clinical trial NCT01720875 · COMPLETED

Trial details

NCT number
NCT01720875
Sponsor
University of Leeds
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-08-09
Primary completion
2015-08-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.